Pathstone Holdings’s Applied Therapeutics APLT Stock Holding History

Pathstone Holdings’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,643,540	Closed	-$305K	–	2230
2025 Q4	$305K	Hold	2,643,540	–	–	﹤0.01%	1964
2025 Q3	$1.6M	Hold	2,643,540	–	–	0.01%	1160
2025 Q2	$822K	Buy	+2,643,540	New	+$1.02M	﹤0.01%	1488

Pathstone Holdings's APLT Position: Q1 2026 in Review

Pathstone Holdings sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 2,643,540 shares — an estimated $305K sold.

Pathstone Holdings first reported a position in APLT in Q2 2025 and held it in 3 quarters. The position peaked at $1.6M in Q3 2025. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

Pathstone Holdings reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
Pathstone Holdings sold 2,643,540 Applied Therapeutics shares in Q1 2026, an estimated $305K.
Pathstone Holdings first reported a position in Applied Therapeutics in Q2 2025 and held it in 3 quarters.
Pathstone Holdings's Applied Therapeutics position peaked at $1.6M in Q3 2025.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Pathstone Holdings's 13F filing for Q1 2026, filed 11 May 2026.